Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. - Wikidata - wikimedia - TriplyDB

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

http://www.wikidata.org/entity/Q33375581

about

Autoimmune dementia: clinical course and predictors of immunotherapy response Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis Autoimmune encephalopathies.IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.Immunologically mediated dementias.Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease.Immunotherapy responsive autoimmune subacute encephalitis: a report of two cases.Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias.Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.Peripherin-IgG association with neurologic and endocrine autoimmunity Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies More than memory impairment in voltage-gated potassium channel complex encephalopathy.Movement disorders in autoimmune diseases.Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.Creutzfeldt-Jakob disease mimicking autoimmune encephalitis with CASPR2 antibodies Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia Autoimmune encephalitis mimicking Creutzfeldt-Jakob disease.Encephalitis and antibodies to synaptic and neuronal cell surface proteins.Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease.Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.The evaluation of rapidly progressive dementia.Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease Chronic pain as a manifestation of potassium channel-complex autoimmunity Diagnosis and treatment of rapidly progressive dementias.Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.Two Unique Cases with Anti-GluR Antibody-Positive Encephalitis Autoimmune Encephalitis LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease.Neuronal autoantigens--pathogenesis, associated disorders and antibody testing Paraneoplastic and other autoimmune disorders of the central nervous system.Ethics in prion disease.Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.

P2860

Q24597504-BA27D151-D6BF-4842-9141-C3880BC9D411 Q24623766-1BDE5E8E-39D3-4F4D-BF92-FB4E4BC97AB8 Q27006941-7AAA0339-C2CB-4690-8E75-418F1C9F04DF Q28298099-314B6D27-875A-4BAE-B713-B2BB8191E393 Q28307624-329FB79E-5B75-4473-B860-9B4E62929AF1 Q30389491-16365A70-661E-4A23-A670-395A33E61B5F Q30454306-34C3B262-B693-44EB-AD29-7368C2FAD93E Q33705494-97F42E23-4E72-4AA3-88A5-68799F4F4031 Q33743698-E134D1FB-B02B-4662-964F-21E3B505A883 Q33746920-8F549640-2017-4BE2-A4C1-7384588AAB6D Q33864510-2CFB69C9-5012-4E8E-9AE8-E25914395BFE Q33933305-3A2AA83B-B598-4119-A2B5-DC58921DE2E7 Q33987193-31129636-A57B-4925-875A-82CB577298EA Q33988689-5A055E47-636E-4D58-9FD2-404CEAC4EE08 Q34007635-B430536C-172D-4411-9FC6-6A9F90FC2792 Q34127075-19BF5F86-BE1F-431D-8EF0-A0344C1CF6A3 Q34173718-E368EFC9-F5F3-4A9C-84F9-176DF9ACF304 Q34272611-7C1DDC92-C5AF-4393-952E-6CFA417F9597 Q34327732-ADF0786B-8865-4A09-9993-3D80F71DBB10 Q34632585-F0770912-C75E-408C-802D-A955F3C453C9 Q34686855-8F591B2E-1722-460E-907D-83D2DE4B795F Q34777846-120B848A-1C0C-4B14-BE55-5212194A7498 Q35117077-95474E45-FE1E-4717-A6F2-16E3E4414B01 Q35500169-BCDCD5F7-FC20-4440-AB15-FF752BE22623 Q35500185-CE3E49A0-BFF0-4145-9D69-E9B23A713C88 Q35677785-BF67C7EA-E6A8-41C9-920D-FF385725C5AB Q35771307-F691116D-2BFC-40C2-9E31-693121DCBD87 Q35974573-4713B648-E481-4A1F-B676-75EE5B4E7290 Q36280873-666978A7-448E-4E6E-A58C-E54E6F8D6033 Q36475267-4660EA6C-5544-40B2-88B7-3DF605AE9195 Q36731518-7AAC043C-5AEA-475E-BA9E-D4898C484E57 Q36813368-9DF5905D-617C-40FD-93C8-52D83D7F854B Q36981016-D68DEE2F-CA6D-48CF-A5F0-2788707CBC25 Q37011779-5F7410EE-875B-43DA-90BC-3D236325DF35 Q37015406-495F06F5-73B8-4475-B4C8-50B02C6396F2 Q37032830-35FEA251-2F7C-46C6-A40A-47D28E832FF5 Q37052800-41B0A617-CA29-4B52-A7EF-323C182114F4 Q37282279-70D27290-E381-4964-9F0C-AD52B4872F66 Q37381059-42B6BA60-7375-4FD9-8CF7-C40B61AE89FA Q37697455-195D4D46-B4EB-4D57-AEC7-CC8603705679

P2860

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

http://www.wikidata.org/entity/Q33375581

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@ast

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@en

type

label

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@ast

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@en

prefLabel

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@ast

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@en

P1433

Q33375581-FEC94A3A-337B-463D-811B-C000522DFE22

P1476

Q33375581-F39C0B22-6EB7-4D19-87F7-AE93D27DB077

P2093

Q33375581-316766E5-017E-4D29-9E21-67EEF68D94F5

Q33375581-92F7EC27-E410-420B-9A69-B9CADEBAE5FB

Q33375581-A17964D7-510C-4350-AC54-070CDE3409A4

Q33375581-A7360A89-1AC5-4088-9096-1D510424EA7F

Q33375581-BD11B026-028C-4E78-B579-3D16A23F662F

Q33375581-E28684C7-3AB7-48EE-B790-791F1215E1B5

Q33375581-F955324A-9A87-4B91-A2BB-AB9A43461ABF

P2860

Q33375581-02929512-E1C1-454B-9237-F988E043740B

Q33375581-04875A1C-CB2B-44AC-B472-0DA24657B9FE

Q33375581-0F47BF76-3798-4FA5-A870-C86D27CD1C76

Q33375581-0FBA3840-97E5-456F-80FB-739EB6919334

Q33375581-3CCD8092-BA63-4128-A6D6-0591038EF584

Q33375581-470A0915-D084-4284-A99D-A3443F2B9580

Q33375581-4EEA5A5B-2D09-458D-BDA5-4B1810CD6096

Q33375581-7746D48F-7C74-4F66-842A-2A4222786A34

Q33375581-7A3987A3-6250-4303-ADBE-896A63AA82E8

Q33375581-7DACA943-3BC1-48A7-95B9-76A4D6A7D234

P304

Q33375581-4E030A48-02F2-49F4-9C29-ED33D16FC666

P31

Q33375581-DB7EB822-56C5-4998-AD53-CB8BF09972DD

P356

Q33375581-5E8CA87B-C34B-4B23-9D03-96EAD405EA23

P433

Q33375581-B09FDBED-9F41-415E-AB5E-78317ACF7D52

P478

Q33375581-D329631D-11C0-4EDD-8822-8B0558A076B5

P50

Q33375581-4AC8CA10-54F5-4E18-91B5-C9F152648DA8

P577

Q33375581-4A9062F2-27F4-4D29-ABA4-967E5AA46F9C

P5875

Q33375581-4EE58DF2-7356-4590-A804-DBA9123E3260

P698

Q33375581-F039AC4E-4F93-4587-A7B5-D464DA7C52B3

P932

Q33375581-135A78E0-147D-4352-A941-056071F7DBB5

P356

ARCHNEUR.65.10.1341

P1433

P1476

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

@en

P2093

Aissa Haman

http://www.w3.org/2001/XMLSchema#string

K Meng Tan

http://www.w3.org/2001/XMLSchema#string

Michael D Geschwind

http://www.w3.org/2001/XMLSchema#string

Ramon F Barajas

http://www.w3.org/2001/XMLSchema#string

S Andrew Josephson

http://www.w3.org/2001/XMLSchema#string

Sean J Pittock

http://www.w3.org/2001/XMLSchema#string

Vanda A Lennon

http://www.w3.org/2001/XMLSchema#string

P2860

Potassium channel antibodies in two patients with reversible limbic encephalitis

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

Clinical spectrum of voltage-gated potassium channel autoimmunity

How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.

Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.

Morvan's syndrome associated with voltage-gated K+ channel antibodies.

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.

Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

P304

1341-1346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.65.10.1341

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J. Klein

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23314627

http://www.w3.org/2001/XMLSchema#string

P698

18852349

http://www.w3.org/2001/XMLSchema#string

P932

2736144

http://www.w3.org/2001/XMLSchema#string